Category: unsubstantiated

analysis, analytics, bad actors, batch, business, cannabinoid, cannabis, cbd, CEO, certificate of analysis, CGMP, claim, COA, compliance, composition, consumer, contents, CV Sciences, dietary, extraction, FDA, Federal, GMP, good manufacturing practices, government, growing, ID, identity, industry, ingredient, Joseph Dowling, lab, label, laboratories, laboratory, labs, law, legal, legalization, legalize, legislation, license, lot, marijuana, market, medical, medicine, number, packaging, potency, product, purity, Quality, regulation, regulations, regulatory, retail, safety, serving, size, state, strength, Testing, thc, unsubstantiated

Bad Actors in CBD: How to Distinguish Quality Products From the Rest

Bad Actors in CBD: How to Distinguish Quality Products From the Rest

The success of reputable cannabis and CBD brands has inspired an influx of inexperienced and disreputable competitors in the market. These so-called […]

action, analysis, analytics, approval, approved, business, Business Analysis, cannabidiol, cannabis, cbd, claim, compliance, Concentrates & Extracts, consumer, Coronavirus, COVID, COVID-19, cultivation, drug, Edibles & Processing, enforcement, extraction, farm bill, FD&C act, FDA, Federal, government, growing, Health, industry, lab, law, legal, legalization, legalize, legislation, letter, license, marijuana, market, medical, medicine, New, product, Product Development, Quality, regulation, regulations, regulatory, research, retail, safety, state, test, Testing, thc, threaten, U.S. Food and Drug Administration, unapproved, unsubstantiated, warning, wellness

FDA Warning Letters: Stop Claiming CBD Prevents COVID

FDA Warning Letters: Stop Claiming CBD Prevents COVID

Once again, the U.S. Food and Drug Administration (FDA) has issued a number of warning letters to companies selling hemp-derived cannabidiol (CBD) […]